Brokerages Set Anteris Technologies Global Corp. (NASDAQ:AVR) Price Target at $16.50

Anteris Technologies Global Corp. (NASDAQ:AVR) has received an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $16.50.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Thursday.

Anteris Technologies Global Stock Performance

AVR opened at $4.31 on Tuesday. Anteris Technologies Global has a fifty-two week low of $2.34 and a fifty-two week high of $8.79. The company has a fifty day moving average of $4.69 and a two-hundred day moving average of $4.17. The stock has a market capitalization of $155.42 million and a price-to-earnings ratio of -3.62.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings data on Monday, August 11th. The company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.05). The business had revenue of $0.62 million for the quarter, compared to the consensus estimate of $0.58 million. On average, equities research analysts forecast that Anteris Technologies Global will post -2.66 earnings per share for the current year.

Institutional Trading of Anteris Technologies Global

Institutional investors and hedge funds have recently modified their holdings of the stock. Corebridge Financial Inc. purchased a new stake in shares of Anteris Technologies Global during the first quarter worth about $27,000. Deutsche Bank AG purchased a new stake in shares of Anteris Technologies Global during the first quarter worth about $59,000. L1 Capital Pty Ltd increased its stake in shares of Anteris Technologies Global by 146.9% during the first quarter. L1 Capital Pty Ltd now owns 6,886,480 shares of the company’s stock worth $25,067,000 after purchasing an additional 4,097,797 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Anteris Technologies Global during the first quarter worth about $91,000. Finally, ADAR1 Capital Management LLC increased its stake in shares of Anteris Technologies Global by 59.4% during the first quarter. ADAR1 Capital Management LLC now owns 1,678,063 shares of the company’s stock worth $6,108,000 after purchasing an additional 625,095 shares in the last quarter.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.